Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sabeeh‑ur‑Rehman Butt"'
Autor:
Sabeeh‑ur‑Rehman Butt, Muhammad S Khan, Carmen Murias, Maria Reyes Gonzalez-Exposito, Hendrik-Tobias Arkenau, Anna Patrikidou
Publikováno v:
Annals of Urologic Oncology (2019)
As research focus in oncology has recently shifted to immunomodulation, the era of introduction of immunotherapeutic agents in the management of prostate cancer has just begun. With the success of checkpoint blockade drugs in certain advanced tumours
Externí odkaz:
https://doaj.org/article/e7565f81b586410fb1aa79859f130df3
Autor:
Hendrik-Tobias Arkenau, Anna Patrikidou, Sabeeh-Ur-Rehman Butt, Alberto Mejias, Marlene Happe, Cristina Morelli, Gonzalo Torga
Publikováno v:
Cancer Chemotherapy and Pharmacology. 87:437-441
The management of cancer has been traditionally dependent on the primary tumour type and specific histologic subtypes. Recently, the introduction of molecular profiling tools and its increasing use in clinical practice has facilitated the emergence o
Autor:
Sabeeh-Ur-Rehman, Butt, Alberto, Mejias, Cristina, Morelli, Gonzalo, Torga, Marlene, Happe, Anna, Patrikidou, Hendrik-Tobias, Arkenau
Publikováno v:
Cancer chemotherapy and pharmacology. 87(3)
The management of cancer has been traditionally dependent on the primary tumour type and specific histologic subtypes. Recently, the introduction of molecular profiling tools and its increasing use in clinical practice has facilitated the emergence o
Autor:
Vincenzo Formica, Tobias Arkenau, Nicola Renzi, Mario Roselli, Anna Patrikidou, Sabeeh-Ur-Rehman Butt, Cristina Morelli, Carmen Murias, A. Nardecchia, Jessica Lucchetti, Kai-Keen Shiu
Publikováno v:
Journal of Clinical Oncology. 38:4530-4530
4530 Background: ICIs demonstrated improved overall survival (OS) in heavily pre-treated mGOJ/GC pts. Pts selection exclusively based on PD-L1 tissue expression appears to be suboptimal, despite data from subgroup analyses of KEYNOTE trials. Strong r
Publikováno v:
Journal of global oncology
Autor:
Sabeeh-ur-Rehman Butt, Laeeq Malik
Publikováno v:
Cancer chemotherapy and pharmacology. 81(4)
As research focus in oncology has recently shifted from oral targeted therapy to immunomodulation, the era of successful drug development in bladder cancer has just begun. This has led to unprecedented approval of five immunotherapeutic agents by reg
Autor:
Catriona Shaw, Jonathon Olsburgh, Dimitrios Kirmizis, Deborah Enting, S. Rudman, Simon Chowdhury, Debra Hannah Josephs, Iain C. Macdougall, Barbara Chow, Sabeeh-Ur-Rehman Butt, Sapna Shah, Rhana Zakri
Publikováno v:
Journal of Clinical Oncology. 37:e16066-e16066
e16066 Background: The increased incidence of cancer after renal transplantation is well recognised. Differences in cancer risk depend on the type of cancer but overall the incidence of solid cancer in kidney transplant recipient is at least twofold.
Autor:
Sabeeh-Ur-Rehman Butt, Julian McNeil
Publikováno v:
Journal of Medical Case Reports
Background Behçet’s disease is a progressive diffuse inflammatory vasculitis characterized by recurrent oral and genital ulceration and ocular inflammation. Cardiac involvement is a rare but well-documented manifestation of Behçet’s disease. Co
Publikováno v:
Internal Medicine Journal. 47:603-603